Skip to search.
 TSX Up 0.38% TSX Ventures Up 0.67%

Celgene Corporation (CELG)

-NasdaqGS
117.65 Down 1.93(1.61%) 4:00PM EDT
|After Hours : 117.16 Down 0.49 (0.42%) 5:29PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:119.58
Open:120.08
Bid:117.16 x 200
Ask:117.48 x 200
1y Target Est:151.78
Beta:2.03731
Earnings Date:Oct 21 - Oct 26 (Est.)
Day's Range:117.09 - 121.14
52wk Range:83.16 - 140.72
Volume:3,790,901
Avg Vol (3m):4,869,780
Market Cap:93.01B
P/E (ttm):44.55
EPS (ttm):2.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 1.61%93.01B
JNJDown 0.76%256.53B

Key Statistics

Forward P/E (1 yr):19.77
P/S (ttm):11.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.78
Quarterly EPS Est (Sep-15) :1.21
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback